Corgentech Drug Fails Trial, Stock Sinks
686804
Shares of Corgentech Inc. fell nearly 50 percent Monday morning after the pharmaceutical company said a drug being developed with Bristol-Myers Squibb Co.
426995
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down more than 8 percent.
163351
MedImmune's shares sank nearly 9 percent yesterday after the company reported weaker-than-expected fourth-quarter revenue for two high-profile products and disclosed a delay in filing for federal approval of a new version of Synagis, its lead drug.
685976
Iridex Corp.  on Friday said its  experimental laser treatment for the leading cause of  age-related blindness was no better than a placebo in a  clinical trial, sending shares down 6 percent.
114185
Shares drop as U.S. regulators say they want more info before approving caner medication Bonefos.
690389
The Dow Jones industrial average fell on Friday after Pfizer Inc. (PFE.N: Quote, Profile, Research) shares opened nearly 19 percent down on trial data for its popular arthritis drug Celebrex that showed increased risk of heart attack.
156273
NEW YORK (CBS.MW) - Shares of GenVec Inc. lost nearly half their value Thursday after the Food and Drug Administration put the company&#39;s TNFerade cancer drug trials on hold.
661254
Shares drop after regulators ask company to prove drug is not inferior to other existing treatments. NEW YORK  - US regulators won&#39;t approve Allergan Inc.
759314
Maxim Pharmaceuticals Inc. MAXM.O  shares plunged nearly 60 percent on Monday after the company  said its experimental liver cancer drug failed to show an  improvement in patient survival rates during a clinical trial.
429530
Shares of biotech firm Pharmos Corp. plunged 77 percent in premarket activity on Monday, after the company reported a late-stage trial of dexanabinol failed to demonstrate efficacy in treating severe traumatic brain injury.
109512
NEW YORK -- Syneron Medical Ltd. stock fell Tuesday after the US Food and Drug Administration delayed approval of the medical device maker&#39;s cellulite product.
233492
Shares in drug giant AstraZeneca fall after a US medical panel recommends that regulators reject its new drug Exanta.
554917
Despite another win, the armored vehicle maker's stock falls.
45410
AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer in a major clinical trial, sending its shares down as much as 9.2 percent.
637430
Pfizer shares plunged in blizzard-like trading volume Friday after the drugmaker said new data from cancer trials showed its arthritis drug Celebrex posed &quot;increased cardiovascular risk&quot; when used in high doses.
428974
Stocks fell on Friday, led by pharmaceutical shares after a US health official raised concerns about drug safety and a drop in chip-equipment makers following a ratings downgrade by Goldman Sachs.
297790
Shares of Accredo Health Inc., which sells drugs to patients with hard-to-treat diseases such as hemophilia and multiple sclerosis, dropped 28 percent after the company said profit in 2005 will fall.